Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Supply Chain
Manufacturing
Eli Lilly's Mounjaro, Zepbound supply outlook worsens
The FDA now expects most doses of the drugs to be in "limited availability" through the second quarter.
Zoey Becker
Apr 18, 2024 10:22am
US shortage tally reaches all-time high, pharmacist group says
Apr 11, 2024 10:12am
Lilly's Mounjaro will be in short supply through April, FDA says
Apr 2, 2024 5:12pm
AZ plans separate drug supply chains for US and China, CEO says
Mar 27, 2024 12:27pm
House Democrats press Teva, Pfizer and Sandoz on drug shortages
Feb 22, 2024 10:44am
Amid supply constraints, Sanofi has big ambitions for Beyfortus
Feb 1, 2024 9:59am